News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Beyer Russell P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
4
| Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.54, valued at
$148.5k
|
|
| 09/15/2022 |
4
| Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 274,875 options to buy
@ $0.71, valued at
$195.2k
|
|
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $11.17, valued at
$1.2M
|
|
| 11/16/2021 |
4
| Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 2,475 shares
@ $10.1, valued at
$25k
Granted 149 shares
@ $10.08, valued at
$1.5k
Granted 129 shares
@ $7.78, valued at
$1k
Sold 278 shares
@ $7.9, valued at
$2.2k
Granted 5 shares
@ $10.07, valued at
$50.4
Granted 10 shares
@ $10.08, valued at
$100.8 |
|
| 10/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|